Coping strategies and patient-reported outcomes (PROs) in early-phase cancer clinical trial (EP-CT) participants

被引：0
|
作者：
Lundquist, Debra
Lam, Anh B.
Pelletier, Andrea
Durbin, Sienna
Petrillo, Laura A.
Jimenez, Rachel
Turbini, Victoria
Bame, Viola
Lynch, Kaitlyn
Yalala, Vaishnavi Reddy
Ollila, Nicholas
Malowitz, Benjamin
McIntyre, Casandra
Juric, Dejan
Nipp, Ryan David
机构：
[1] Massachusetts Gen Hosp, Henri & Belinda Termeer Ctr Targeted Therapies, Boston, MA USA
[2] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA
[3] Brigham & Womens Hosp, Boston, MA USA
[4] Massachusetts Gen Hosp, Boston, MA USA
[5] Univ Oklahoma, Oklahoma City, OK USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e23194
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Molecular Profiling of Metastatic Bladder Cancer Early-Phase Clinical Trial Participants Predicts Patient Outcomes
    Alhalabi, Omar
    Hahn, Andrew W.
    Msaouel, Pavlos
    Andreev-Drakhlin, Alexander Y.
    Meric-Bernstam, Funda
    Naing, Aung
    Piha-Paul, Sarina
    Filip, Janku
    Pant, Shubham
    Yap, Timothy A.
    Hong, David S.
    Fu, Siqing
    Karp, Daniel
    Campbell, Erick
    Le, Hung
    Campbell, Matthew T.
    Shah, Amishi Y.
    Tannir, Nizar M.
    Siefker-Radtke, Arlene O.
    Gao, Jianjun
    Roszik, Jason
    Subbiah, Vivek
    MOLECULAR CANCER RESEARCH, 2021, 19 (03) : 395 - 402
  • [12] PATIENT-REPORTED OUTCOMES (PROS) IN OVARIAN CANCER CLINICAL TRIALS
    Pease, S.
    Barsdorf, A., I
    VALUE IN HEALTH, 2015, 18 (03) : A210 - A210
  • [13] Financial toxicity in early-phase cancer clinical trial participants
    Durbin, Sienna M.
    Lundquist, Debra
    Pelletier, Andrea
    Petrillo, Laura A.
    Bame, Viola
    Turbini, Victoria
    Heldreth, Hope
    Lynch, Kaitlyn
    Boulanger, Mary
    Lam, Anh
    Mcintyre, Casandra
    Ferrell, Betty R.
    Jimenez, Rachel
    Juric, Dejan
    Nipp, Ryan D.
    CANCER, 2025, 131 (01)
  • [14] PATIENT-REPORTED OUTCOMES (PROS) IN BLADDER CANCER
    Barsdorf, A., I
    Pease, S.
    VALUE IN HEALTH, 2015, 18 (03) : A210 - A210
  • [15] Using Patient-Reported Outcomes (PROs) in Early-Phase Dose-finding Oncology Trials (EDOT): a global survey
    Lai-Kwon, Julia
    Vanderbeek, Alyssa
    Minchom, Anna
    Yap, Christina
    QUALITY OF LIFE RESEARCH, 2021, 30 (SUPPL 1) : S23 - S23
  • [16] Patient-reported outcomes (PROs) in pancreatic cancer clinical trials (CTs)
    Grewal, Udhayvir Singh
    Ahmed, Danya
    Dhaliwal, Lovekirat Singh
    Laheru, Daniel A.
    Lou, Emil
    Beg, Muhammad Shaalan
    Nipp, Ryan David
    Gupta, Arjun
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [17] Development and implementation of a systematic approach to measure patient-reported outcomes in early-phase cancer trials
    King, Amanda L.
    Levine, Jason E.
    Vera, Elizabeth
    Gandhi, Yuti
    Novakovich, Elaine
    Yu, Theresa
    Berhanu, Sefanit
    Locke, Ciara
    Julmeus, Kaelyn
    Mendoza, Tito
    Armstrong, Terri S.
    CANCER RESEARCH, 2024, 84 (06)
  • [18] Patient-reported hope, quality of life (QOL), symptom burden, and coping mechanisms in early phase clinical trial participants.
    Lundquist, Debra
    Pelletier, Andrea
    Durbin, Sienna
    Bame, Viola
    Turbini, Victoria
    Healy, Megan
    Lynch, Kaitlyn
    McIntyre, Casandra
    Juric, Dejan
    Ferrell, Betty R.
    Jimenez, Rachel
    Nipp, Ryan David
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [19] Understanding the supportive care needs of early-phase cancer clinical trial ( CT) participants.
    Lundquist, Debra
    Juric, Dejan
    Jimenez, Rachel
    Capasso, Virginia
    McIntyre, Casandra
    Cashavelly, Barbara J.
    Johnson, Andrew
    Healy, Megan
    Nipp, Ryan David
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (29)
  • [20] PATIENT-REPORTED OUTCOMES (PROS) IN DIABETES CLINICAL TRIALS
    Barsdorf, A., I
    Rubinstein, E.
    Jaksa, A.
    VALUE IN HEALTH, 2013, 16 (03) : A168 - A169
12345